Track the Novanta, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was filed on 2 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Matthijs Glastra. All data is accessible without an account.
Analysts rate Novanta, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Novanta, Inc. 是一家精密技术公司,为成像、自动化和医疗市场提供解决方案。该公司在纳斯达克上市,股票代码为 NOVT。